摘要 |
<p>The present invention relates to novel compounds representated by formula (I), where R, R1, R2, R3, X, Y, m, n are as defined.The present invention r elates to compounds of the general formula I their derivatives, their analog s, their tautomeric forms, their stereoisomers, their diastereomers, their b ioisosteres, their polymorphs, their pharmaceutically acceptable salts and p harmaceutically acceptable compositions containing them which are predominan tly dipeptidyl peptidase IV inhibitors. The present invention also relates t o the processes for the preparation of novel compounds of formula (I) and th eir use in treating type II diabetes and diabetic complications thereof and also for treating dislipidemia, hypercholesterolemia, obesity and hyperglyce mia.</p> |